Abstract:BACKGROUND:Randomized controlled trials are considered the gold standard for evaluating experimental treatments but often require large sample sizes. Single-arm trials require smaller sample sizes but are subject to bias when using historical control data for comparative inferences. This article presents a Bayesian adaptive synthetic-control design that exploits historical control data to create a hybrid of a single-arm trial and a randomized controlled trial.METHODS:The Bayesian adaptive synthetic control design has two stages. In stage 1, a prespecified number of patients are enrolled in a single arm given the experimental treatment. Based on the stage 1 data, applying propensity score matching and Bayesian posterior prediction methods, the usefulness of the historical control data for identifying a pseudo sample of matched synthetic-control patients for making comparative inferences is evaluated. If a sufficient number of synthetic controls can be identified, the single-arm trial is continued. If not, the trial is switched to a randomized controlled trial. The performance of The Bayesian adaptive synthetic control design is evaluated by computer simulation.RESULTS:The Bayesian adaptive synthetic control design achieves power and unbiasedness similar to a randomized controlled trial but on average requires a much smaller sample size, provided that the historical control data patients are sufficiently comparable to the trial patients so that a good number of matched controls can be identified in the historical control data. Compared to a single-arm trial, The Bayesian adaptive synthetic control design yields much higher power and much smaller bias.CONCLUSION:The Bayesian adaptive synthetic-control design provides a useful tool for exploiting historical control data to improve the efficiency of single-arm phase II clinical trials, while addressing the problem of bias when comparing trial results to historical control data. The proposed design achieves power similar to a randomized controlled trial but may require a substantially smaller sample size.

Utility-based optimization of Fujikawa's basket trial design -- Pre-specified protocol of a comparison study

A Phase I-II Basket Trial Design to Optimize Dose-Schedule Regimes Based on Delayed Outcomes.

Systematic comparison of Bayesian basket trial designs with unequal sample sizes and proposal of a new method based on power priors

How to Add Baskets to an Ongoing Basket Trial with Information Borrowing

Analyzing Basket Trials under Multisource Exchangeability Assumptions

A Bayesian Basket Trial Design Using Local Power Prior

baskexact: An R package for analytical calculation of basket trial operating characteristics

BLAST: Bayesian Latent Subgroup Design for Basket Trials Accounting for Patient Heterogeneity

A Utility-Based Design for Randomized Comparative Trials with Ordinal Outcomes and Prognostic Subgroups

New clinical trial design borrowing information across patient subgroups based on fusion-penalized regression models

Optimizing Trial Designs for Targeted Therapies

Augmented Binary Method for Basket Trials (ABBA)

Bayesian Methods for Information Borrowing in Basket Trials: An Overview

A Bayesian Platform Trial Design to Simultaneously Evaluate Multiple Drugs in Multiple Indications with Mixed Endpoints.

A Calibrated Power Prior Approach to Borrow Information from Historical Data with Application to Biosimilar Clinical Trials.

Improving Adaptive Seamless Designs through Bayesian optimization

BASIC: A Bayesian Adaptive Synthetic-Control Design for Phase II Clinical Trials.

A Bayesian Basket Trial Design Using a Calibrated Bayesian Hierarchical Model

An Adaptive Trial Design to Optimize Dose-Schedule Regimes with Delayed Outcomes

A Nonparametric Bayesian Basket Trial Design

Frequentist analysis of basket trials with one-sample Mantel-Haenszel procedures